Germany · 
Who invested in Refoxy Pharma?
Refoxy Pharma's investors include Apollo and Boehringer Ingelheim Venture Fund.
Germany · Seed startup
Who invested in Refoxy Pharma
Funding summaryUpdated 26 Oct 2026
$9.6Mraised across 1 round since 2024, from 1 source
- Latest round
- Seed, $9.6MDec 2024
- Investors
- 2
The rounds
- Dec 2024
Founders and team
From Refoxy Pharma's own website: 1 founder, 5 on the team.
- Dr. Andrew PierceChief Science Officer
- Björn GeigleDirector of Bioinformatics
- Dorottya KeppelDirector of Drug Discovery
- Dr. Camille GignouxDirector of Medicinal Chemistry
- Sarah NielsenOperations Manager and Executive Assistant
AdvisersProf. Wolfgang Link
Everyone who backed them
Boehringer Ingelheim Venture FundCorporate VC1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Refoxy Pharma
How much has Refoxy Pharma raised?
Refoxy Pharma has raised $9.6M across 1 round since 2024.
When did Refoxy Pharma last raise?
Refoxy Pharma's most recent round was a Seed of $9.6M in Dec 2024.
What was Refoxy Pharma's biggest round?
Its most recent round, $9.6M in Dec 2024, is also its largest on record.
Who backed Refoxy Pharma first?
Refoxy Pharma's first round on record, in Dec 2024, was backed by Apollo and Boehringer Ingelheim Venture Fund.
What stage is Refoxy Pharma at?
Refoxy Pharma's latest named round is a Seed, in Dec 2024.
Where is Refoxy Pharma based?
Refoxy Pharma is based in Germany.
Companies like Refoxy Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.